# Oruka Therapeutics, Inc. (ORKA): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/orka for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequentia...

## Quote & Key Metrics

As of 2026-10-27:

| Metric | Value |
|---|---|
| Price | $95.81 USD |
| Market Cap | $6.34B |
| P/E (TTM) | — |
| EPS (TTM) | −$2.03 |
| 52-Week Range | $25.23 – $115.52 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Special |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | — / — / — / — |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

## Frequently Asked Questions

### What does Oruka Therapeutics, Inc. do?

Oruka Therapeutics, Inc. (ORKA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ORKA's market cap?

Oruka Therapeutics, Inc. (ORKA) has a market capitalization of approximately $6.34 billion, as of October 27, 2026, based on the most recent share price and shares outstanding.

### Does ORKA pay a dividend?

No, Oruka Therapeutics, Inc. (ORKA) is not currently paying a dividend. Its last ex-dividend date was August 29, 2024 ($19.36 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### Is ORKA profitable?

Oruka Therapeutics, Inc. (ORKA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### How often did ORKA pay dividends?

Oruka Therapeutics, Inc. paid dividends special until 2024; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is ORKA's payout ratio?

Oruka Therapeutics, Inc.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/orka
- Dividend history & safety: https://www.dividenddata.com/stocks/orka/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/orka/earnings
- Financial statements: https://www.dividenddata.com/stocks/orka/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/orka/valuation
- Peer comparison: https://www.dividenddata.com/stocks/orka/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.